Furthermore, G‐CSF can stimulate quiescent G0‐phase cells to enter the G1 phase and mobilize bone marrow leukemic cells to the peripheral blood, thereby sensitizing ETP‐ALL cells to therapeutic agents [46]. Here, CSF3 is linked to acute lymphoblastic leukemia.